Skip to main content
Clinical Trials/DRKS00013750
DRKS00013750
Completed
Not Applicable

Prospective, longitudinal, observational study of novel serum/plasma biomarkers of disease activity in patients with inflammatory bowel disease

Medizinische Hochschule Hannover0 sites60 target enrollmentMarch 22, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
K50
Sponsor
Medizinische Hochschule Hannover
Enrollment
60
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 22, 2018
End Date
December 31, 2018
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Medizinische Hochschule Hannover

Eligibility Criteria

Inclusion Criteria

  • Outpatient visit for study\-independent medical reasons
  • \- Patients with a) Crohn's disease, b) Ulcerative Colitis, c) Microscopic colitis
  • \- Patients before therapy start with an (extended) anti\-inflammatory treatment (5\-ASA, Budesonid, Prednisolon, Azathioprin, Methotrexat, anti\-TNF, Vedolizumab, Ustekinumab, Tofacitinib)

Exclusion Criteria

  • \- Diseases which prevent the patient from understanding the nature and the concept of the clinical trial
  • \- Indications that the patient will presumably not comply with the protocol (e.g. adherence problem)

Outcomes

Primary Outcomes

Not specified

Similar Trials